[go: up one dir, main page]

DE60006814D1 - Dinucleotid-kristalle - Google Patents

Dinucleotid-kristalle

Info

Publication number
DE60006814D1
DE60006814D1 DE60006814T DE60006814T DE60006814D1 DE 60006814 D1 DE60006814 D1 DE 60006814D1 DE 60006814 T DE60006814 T DE 60006814T DE 60006814 T DE60006814 T DE 60006814T DE 60006814 D1 DE60006814 D1 DE 60006814D1
Authority
DE
Germany
Prior art keywords
dcp4u
present
crystals
monophosphate
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006814T
Other languages
English (en)
Other versions
DE60006814T2 (de
Inventor
Kenya Mori
Takanori Miyashita
Hideaki Maeda
Hiroshi Sato
Yutaka Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Corp
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Application granted granted Critical
Publication of DE60006814D1 publication Critical patent/DE60006814D1/de
Publication of DE60006814T2 publication Critical patent/DE60006814T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60006814T 1999-06-30 2000-06-30 Dinucleotid-kristalle Expired - Lifetime DE60006814T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18495099 1999-06-30
JP18495099 1999-06-30
PCT/JP2000/004336 WO2001002416A1 (en) 1999-06-30 2000-06-30 Dinucleotide crystals

Publications (2)

Publication Number Publication Date
DE60006814D1 true DE60006814D1 (de) 2004-01-08
DE60006814T2 DE60006814T2 (de) 2004-05-19

Family

ID=16162200

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60006814T Expired - Lifetime DE60006814T2 (de) 1999-06-30 2000-06-30 Dinucleotid-kristalle
DE60021629T Expired - Lifetime DE60021629T2 (de) 1999-06-30 2000-06-30 Dinukleotid-Kristalle

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60021629T Expired - Lifetime DE60021629T2 (de) 1999-06-30 2000-06-30 Dinukleotid-Kristalle

Country Status (22)

Country Link
US (1) US6617444B1 (de)
EP (2) EP1191032B1 (de)
JP (1) JP3421666B2 (de)
KR (1) KR100593723B1 (de)
CN (1) CN1144811C (de)
AT (2) ATE300551T1 (de)
AU (1) AU767136B2 (de)
BR (1) BR0012205A (de)
CA (1) CA2376860C (de)
CZ (1) CZ303172B6 (de)
DE (2) DE60006814T2 (de)
EA (1) EA004707B1 (de)
ES (2) ES2245431T3 (de)
HU (1) HU229225B1 (de)
IL (1) IL147163A (de)
MX (1) MXPA02000035A (de)
NO (1) NO321169B1 (de)
NZ (1) NZ516301A (de)
PL (2) PL202200B1 (de)
SK (1) SK284178B6 (de)
WO (1) WO2001002416A1 (de)
ZA (1) ZA200110468B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223744B2 (en) 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US6818629B2 (en) 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US7078391B2 (en) 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US6872710B2 (en) 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
US6548658B2 (en) * 1997-07-25 2003-04-15 Inspire Pharmaceuticals, Inc. Di-(uridine 5′)-tetraphosphate and salts thereof
DE60006814T2 (de) * 1999-06-30 2004-05-19 Yamasa Corp., Choshi Dinucleotid-kristalle
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
US7161029B2 (en) * 2003-12-17 2007-01-09 Ajinomoto Co., Inc. DiL-lysine monosulfate trihydrate crystal and method of making
CN100363376C (zh) * 2006-06-12 2008-01-23 南京工业大学 一种5’-核苷三磷酸钠盐的结晶方法
KR102116170B1 (ko) * 2015-06-29 2020-05-27 야마사 쇼유 가부시키가이샤 P1, p4-비스(5''-우리딜)테트라포스페이트 결정의 보관 방법
CA3039053C (en) * 2016-10-25 2021-04-20 Yamasa Corporation Method for purifying p1,p4-di(uridine 5'-)tetraphosphate
CN111253456B (zh) * 2020-03-13 2021-05-11 广东先强药业有限公司 一种地纽福索钠的制备方法
CN111704637A (zh) * 2020-06-28 2020-09-25 南京工业大学 一种采用膜蒸馏结晶精制核苷酸的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242685A (ja) * 1994-01-12 1995-09-19 Unitika Ltd ジアデノシン四リン酸水和物の製造方法
US5837861A (en) * 1997-02-10 1998-11-17 Inspire Pharmaceuticals, Inc. Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US6348589B1 (en) 1997-02-06 2002-02-19 Inspire Pharmaceuticals, Inc. Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
US6596725B2 (en) * 1997-02-10 2003-07-22 Inspire Pharmaceuticals, Inc. Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
TW593331B (en) * 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
NZ501696A (en) * 1997-07-25 2001-08-31 Inspire Pharmaceuticals Inc Method for large-scale production of sodium and ammonium salts of di(uridine 5')-tetraphosphate
ATE232733T1 (de) * 1998-05-22 2003-03-15 Inspire Pharmaceuticals Inc Therapeutische dinucleotide und deren derivate
CN1151166C (zh) * 1998-10-02 2004-05-26 雅玛山酱油株式会社 二尿苷四磷酸或其盐的晶体和其制备方法、以及制备该化合物的方法
WO2000039145A1 (en) * 1998-12-23 2000-07-06 The University Of North Carolina At Chapel Hill Targeted gene transfer using g protein coupled receptors
DE60006814T2 (de) * 1999-06-30 2004-05-19 Yamasa Corp., Choshi Dinucleotid-kristalle

Also Published As

Publication number Publication date
ATE255123T1 (de) 2003-12-15
ZA200110468B (en) 2003-04-04
MXPA02000035A (es) 2003-07-21
DE60021629T2 (de) 2006-01-05
JP3421666B2 (ja) 2003-06-30
IL147163A0 (en) 2002-08-14
EP1362862B1 (de) 2005-07-27
EA200200109A1 (ru) 2002-06-27
BR0012205A (pt) 2002-05-28
ES2211566T3 (es) 2004-07-16
CN1144811C (zh) 2004-04-07
EP1191032A1 (de) 2002-03-27
SK18702001A3 (sk) 2002-06-04
EP1191032A4 (de) 2002-07-17
ATE300551T1 (de) 2005-08-15
HUP0201531A2 (en) 2002-08-28
CN1359387A (zh) 2002-07-17
EA004707B1 (ru) 2004-06-24
HUP0201531A3 (en) 2005-02-28
DE60021629D1 (de) 2005-09-01
PL352363A1 (en) 2003-08-25
WO2001002416A1 (en) 2001-01-11
PL202200B1 (pl) 2009-06-30
CA2376860C (en) 2006-11-07
SK284178B6 (sk) 2004-10-05
KR20020028903A (ko) 2002-04-17
NO20016381L (no) 2002-02-28
NZ516301A (en) 2003-07-25
IL147163A (en) 2005-11-20
US6617444B1 (en) 2003-09-09
DE60006814T2 (de) 2004-05-19
KR100593723B1 (ko) 2006-06-30
ES2245431T3 (es) 2006-01-01
CZ303172B6 (cs) 2012-05-09
EP1362862A1 (de) 2003-11-19
PL202176B1 (pl) 2009-06-30
HU229225B1 (en) 2013-09-30
EP1191032B1 (de) 2003-11-26
CA2376860A1 (en) 2001-01-11
NO20016381D0 (no) 2001-12-27
AU5706700A (en) 2001-01-22
NO321169B1 (no) 2006-03-27
AU767136B2 (en) 2003-10-30
CZ20014502A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
ATE300551T1 (de) Dinukleotid-kristalle
CA2028151A1 (en) Antiviral compounds
NO20011634D0 (no) Krystall av diuridintetrafosfat eller salter derav, og fremgangsmåte for fremstilling av samme og fremgangsmåte for fremstilling av nevnte forbindelse
SG63554A1 (en) 5-methyluridine process for large scale preparation of 2 ,3- didehydro-3' deoxythymidine (d4t)
ES2019685B3 (es) Procedimiento para la fabricacion de productos firmes o en forma de pasta
RU95108553A (ru) Способ получения нуклеозидных аналогов с использованием бициклических промежуточных продуктов
CA2135853A1 (en) Process for large-scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides
EA199900291A1 (ru) Натриевая соль поли-(2,5-дигидрокси-фенилен)-4-тиосульфокислоты линейного строения как регулятор метаболизма клетки и способ ее получения
RU95103392A (ru) Способ получения 1-гидроксиадамантана
EP0590539A3 (de) Tetrathiafulvalene Derivate Vorlaüfer, Terathiafulvalene Derivate und Verfahren zu deren Herstellung
JPS565458A (en) Preparation of 1-ethyl-2- 2-methoxy-5- sulfamoylbenzamidemethyl pyrrolidine
KR100325682B1 (ko) 2',3'-디디하이드로-2',3'-디데옥시시티딘 유도체의 제조방법
JPS6490161A (en) Production of optically active cyanohydrin or its enantiomer
TH36855A (th) กระบวนการสำหรับการเตรียมกรดแอล-แอสคอร์บิก
JPH0667940B2 (ja) ２’，３’‐ジデオキシプリンヌクレオシド類の製造方法
TH13050A (th) สารประกอบทางเภสัช
CA2024796A1 (en) Process for producing chlorosulfonyl isocyanate
KR960014130A (ko) 세펨 유도체의 제조방법
TH38735A3 (th) กระบวนการสำหรับการผลิตตะแกรงโมเลกุล
LV12664A (lv) Synthesis of 4-substituted 2-oxobutenic acid sodium salts

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1191032

Country of ref document: EP

Representative=s name: GUENTER WAECHTERSHAEUSER, 80333 MUENCHEN, DE